Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Daniel M, Kolansky"'
Autor:
J. David Smeijer, Jeroen Koomen, Donald E. Kohan, John J.V. McMurray, George L. Bakris, Ricardo Correa-Rotter, Fan-Fan Hou, James L. Januzzi, Dalane W. Kitzman, Daniel M. Kolansky, Hirofumi Makino, Vlado Perkovic, Sheldon Tobe, Hans-Henrik Parving, Dick de Zeeuw, Hiddo J.L. Heerspink
Publikováno v:
JACC Heart Fail
JACC. Heart failure, 10(7), 498-507. ELSEVIER SCI LTD
JACC. Heart failure, 10(7), 498-507. ELSEVIER SCI LTD
BACKGROUND: The endothelin receptor antagonist atrasentan reduced the risk of kidney failure in patients with type 2 diabetes mellitus and chronic kidney disease (CKD) in the SONAR (Study of Diabetic Nephropathy with Atrasentan) trial, although with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee5cb0019ff35f8d70ca9f0ea04c8b5b
https://doi.org/10.1016/j.jchf.2022.03.004
https://doi.org/10.1016/j.jchf.2022.03.004
Autor:
Amaryah Yaeger, Nancy R. Cash, Tara Parham, David S. Frankel, Rajat Deo, Robert D. Schaller, Pasquale Santangeli, Saman Nazarian, Gregory E. Supple, Jeffrey Arkles, Michael P. Riley, Fermin C. Garcia, David Lin, Andrew E. Epstein, David J. Callans, Francis E. Marchlinski, Daniel M. Kolansky, Jorge I. Mora, Anastassia Amaro, Richard Schwab, Allan Pack, Sanjay Dixit
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 23 (2018)
Background Obesity and obstructive sleep apnea (OSA) are associated with atrial fibrillation (AF), yet these conditions remain inadequately treated. We report on the feasibility and efficacy of a nurse‐led risk factor modification program utilizing
Externí odkaz:
https://doaj.org/article/738ebdbf20014ed39df2037d0e142785
Autor:
Glenda Hoffecker, Genevieve P Kanter, Yao Xu, William Matthai, Daniel M Kolansky, Jay Giri, Sony Tuteja
Publikováno v:
Personalized Medicine. 19:41-49
Aim: To determine if interventional cardiologists’ knowledge and attitudes toward pharmacogenetic (PGx) testing influenced their antiplatelet prescribing decisions in response to CYP2C19 results. Materials & methods: Surveys were administered prior
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddad37238014856caae82c78bb826d92
https://doi.org/10.2217/pme-2021-0088
https://doi.org/10.2217/pme-2021-0088
Autor:
Robert W. Yeh, Craig S. Parzynski, Daniel M. Kolansky, Debabrata Mukherjee, Jay Giri, Alexander C. Fanaroff, Saurav Chatterjee, Jeptha P. Curtis, Thomas M. Maddox
Publikováno v:
JACC: Cardiovascular Interventions. 14:2344-2349
Objectives The study sought to assess the proportion of patients in modern U.S. interventional practice that fulfilled criteria for enrollment in the ISCHEMIA (International Study of Comparative Health Effectiveness With Medical and Invasive Approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39d563f8e38f7b9bfb5f15ffd4eb95e8
https://doi.org/10.1016/j.jcin.2021.08.047
https://doi.org/10.1016/j.jcin.2021.08.047
Autor:
Abid Assali, De Bruyne B, Martin B. Leon, Stephan Achenbach, Gabriel Greenberg, Ran Kornowski, Allen Jeremias, Ajay J. Kirtane, Thomas McAndrew, Daniel M. Kolansky, Stephane Fournier, Thomas Engstrom, Mitsuaki Matsumura, Richard Shlofmitz, Ovidiu Dressler, Rami Jubeh, Yuhei Kobayashi, William F. Fearon, Carlos Collet, Ziad A. Ali, Akiko Maehara
Publikováno v:
EuroIntervention. 17:e294-e300
BACKGROUND A large, prospective, multicentre trial recently showed that fractional flow reserve (FFR) derived from coronary angiography (FFRangio) has an accuracy of 92% compared with conventional guidewire-based FFR (FFRwire); however, little is kno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::456f09de267f994a1f1452f88c6ab3b4
https://doi.org/10.4244/eij-d-19-00933
https://doi.org/10.4244/eij-d-19-00933
Autor:
David J. Slotwiner, Srihari S. Naidu, James C. Blankenship, Jayant Bagai, Daniel M. Kolansky, Manesh R. Patel, Sohah N. Iqbal, J. Dawn Abbott, Santiago Garcia, Matheen A. Khuddus, Kimberly A. Skelding, Steven V. Manoukian, Prashant Kaul, Rajesh V. Swaminathan, Lorrena Kirkwood, Frederick G.P. Welt
Publikováno v:
Catheterization and Cardiovascular Interventions. 98:255-276
The current document commissioned by the Society for Cardiovascular Angiography and Interventions (SCAI) and endorsed by the American College of Cardiology, the American Heart Association, and Heart Rhythm Society represents a comprehensive update to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed39c555579a770cb567af418f2c444d
https://doi.org/10.1002/ccd.29744
https://doi.org/10.1002/ccd.29744
Autor:
Daniel M. Kolansky, Sammy Elmariah, John C. Messenger, Pradeep Yadav, Santiago Garcia, David F. Kong, James C. Blankenship, Dmitriy N. Feldman, Islam Y. Elgendy, Debabrata Mukherjee, Bryan H. Goldstein, James W. Choi, Ravi S. Hira, Mehdi H. Shishehbor, Rajan A.G. Patel, Howard C. Herrmann, Clifford J. Kavinsky, Vikas Singh, Robert N. Piana, Gagan D. Singh, Emily Senerth, David A. Cox, Ankur Kalra, Michael R. Jaff, Edo Kaluski, Molly Szerlip, Herbert D. Aronow
Publikováno v:
Catheterization and Cardiovascular Interventions. 96:145-155
Evidence-based recommendations for clinical practice are intended to help health care providers and patients make decisions, minimize inappropriate practice variation, promote effective resource use, improve clinical outcomes, and direct future resea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2691a413a01dbbd7cd9b93cb3ffb02f0
https://doi.org/10.1002/ccd.28754
https://doi.org/10.1002/ccd.28754
Autor:
Grace Lee, Lisa A Varughese, Laura Conway, Carol Stojinski, Sandhya Ashokkumar, Karen Monono, William Matthai, Daniel M Kolansky, Jay Giri, Sony Tuteja
Publikováno v:
Per Med
Pharmacogenetic (PGx) testing looks for genetic variations that may impact one's ability to respond to certain medications. This has the potential to improve patient care and minimize side effects from medications but is not currently used as standar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01e5ae4c586e6ce7493bf1a68d45ebfa
https://europepmc.org/articles/PMC8885847/
https://europepmc.org/articles/PMC8885847/
Autor:
Bryce V, Johnson, Edward R, Horton, Christopher, Domenico, Ashwin S, Nathan, Alexander C, Fanaroff, Michael A, Acker, Daniel M, Kolansky
Publikováno v:
The Journal of invasive cardiology. 33(12)
We aimed to characterize outcomes associated with cangrelor administration used in an antiplatelet bridging strategy in real-world clinical scenarios within a large academic medical system.Cangrelor has been used for antiplatelet bridging in perioper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::46c85ccfb7a2b0d9d33b66f935470dcb
https://pubmed.ncbi.nlm.nih.gov/34817395
https://pubmed.ncbi.nlm.nih.gov/34817395
Autor:
Luiz F. Ybarra, Michael J. Lim, Suzanne J. Baron, Louis A. Cannon, Ronald P. Caputo, Joaquin E. Cigarroa, George D. Dangas, Cindy L. Grines, Daniel M. Kolansky, Srihari S. Naidu, Sunil V. Rao, Arnold Seto, Timothy D. Henry, Connie S. Baumgard, Blake Bell, Ilka Bijoux, Dom Didonato, Dustin Dunham, Vanessa Long, Linda Lonn, Elizabeth Martin, Bryan Moriarty, Scott Shadiow, Vinod Sharma, Nick E.J. West, Steve Zizzo
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions. 2:100456
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dcb57ac017860ed913344e4bd9905e3
https://doi.org/10.1016/j.jscai.2022.100456
https://doi.org/10.1016/j.jscai.2022.100456